<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="csnb" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">csnb</book-part-id>
      <title-group>
        <title>X-Linked Congenital Stationary Night Blindness</title>
        <alt-title alt-title-type="alt-title">Synonym: X-Linked CSNB</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boycott</surname>
            <given-names>Kym M</given-names>
          </name>
          <degrees>PhD, MD</degrees>
          <aff>Clinical Geneticist, Department of Genetics<break/>Children's Hospital of Eastern Ontario<break/>Associate Professor, Department of Pediatrics<break/>University of Ottawa<break/>Ottawa, Ontario, Canada</aff>
          <email>kboycott@cheo.on.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sauv&#x000e9;</surname>
            <given-names>Yves</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Departments of Ophthalmology and Physiology <break/>University of Alberta<break/>Edmonton, Alberta, Canada</aff>
          <email>ysauve@ualberta.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>MacDonald</surname>
            <given-names>Ian M</given-names>
          </name>
          <degrees>MD, CM</degrees>
          <aff>Departments of Ophthalmology and Medical Genetics<break/>University of Alberta<break/>Edmonton, Alberta, Canada</aff>
          <email>macdonal@ualberta.ca</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>16</day>
          <month>1</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>26</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mtm" document-type="chapter">X-Linked Centronuclear Myopathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="xdp" document-type="chapter">X-Linked Dystonia-Parkinsonism</related-object>
      <abstract id="csnb.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>X-linked congenital stationary night blindness (CSNB) is characterized by: non-progressive retinal findings of reduced visual acuity ranging from 20/30 to 20/200; defective dark adaptation; refractive error, most typically myopia ranging from low (-0.25 diopters [D] to -4.75 D) to high (&#x02265;-10.00 D) but occasionally hyperopia; nystagmus; strabismus; normal color vision; and normal fundus examination. Two overlapping, yet distinct, phenotypes are recognized:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete CSNB (CSNB1A), caused by pathogenic variants in <italic toggle="yes">NYX</italic> (45%)</p>
            </list-item>
            <list-item>
              <p>Incomplete CSNB (CSNB2A), caused by pathogenic variants in <italic toggle="yes">CACNA1F</italic> (55%)</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis is based on clinical findings, characteristic findings on electroretinography (ERG), family history, and molecular genetic testing of <italic toggle="yes">NYX</italic> and <italic toggle="yes">CACNA1F</italic>, the only two genes in which mutation is known to cause X-linked CSNB.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Glasses or contact lenses to treat refractive error (myopia or hyperopia); conventional strabismus surgery may be required to improve binocularity or head posture.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> On occasion, strabismus surgery to improve functional range of null point.</p>
          <p><italic toggle="yes">Surveillance:</italic> At a young age yearly eye examinations with refraction to identify and treat myopia as early as possible.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Reduced visual acuity and difficulties seeing at night may preclude driving a car or restrict the class of driving license.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>X-linked CSNB is inherited in an X-linked manner. The father of an affected male will not have X-linked CSNB nor will he be a carrier of the pathogenic variant. If the mother of the proband is a carrier, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and will usually not be affected. Males with X-linked CSNB will pass the pathogenic variant to all of their daughters and none of their sons. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible for families in which the pathogenic variant has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="csnb.Diagnosis">
        <title>Diagnosis</title>
        <sec id="csnb.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <sec id="csnb.Affected_Males">
            <title>Affected Males</title>
            <p>A clinical diagnosis of X-linked congenital stationary night blindness (X-linked CSNB) can be made in a male with the following findings:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Reduced visual acuity.</bold> Vision is reduced in all affected males in the range of 20/30 (6/9; log MAR 0.1) to 20/200 (6/60; log MAR 1.0).</p>
              </list-item>
              <list-item>
                <p><bold>History of defective dark adaptation.</bold> Night blindness is a subjective finding; see <bold>Characteristic findings on ERG</bold> (electroretinography) for explanation of CSNB types 1 and 2.</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Individuals with CSNB1A (complete X-linked CSNB caused by mutation of <italic toggle="yes">NYX</italic>) generally report severe night blindness.</p>
                  </list-item>
                  <list-item>
                    <p>Individuals with CSNB2A (incomplete X-linked CSNB caused by mutation of <italic toggle="yes">CACNA1F</italic>) do not uniformly report severe night blindness.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Myopia.</bold> Myopia may range from low (-0.25 diopters [D] to -4.75 D) to high (&#x02265; -10.00 D) [<xref ref-type="bibr" rid="csnb.REF.boycott.2000.204">Boycott et al 2000</xref>, <xref ref-type="bibr" rid="csnb.REF.allen.2003.1413">Allen et al 2003</xref>]. A few affected individuals have hyperopia.</p>
              </list-item>
              <list-item>
                <p>
                  <bold>Nystagmus and strabismus</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>50%-70% of affected individuals have nystagmus and strabismus [<xref ref-type="bibr" rid="csnb.REF.boycott.2000.204">Boycott et al 2000</xref>, <xref ref-type="bibr" rid="csnb.REF.allen.2003.1413">Allen et al 2003</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Transient head posture with nystagmus was noted in the first two years of life in eight individuals with X-linked CSNB secondary to pathogenic variants in <italic toggle="yes">CACNA1F</italic> and one with a pathogenic variant in <italic toggle="yes">NYX</italic> [<xref ref-type="bibr" rid="csnb.REF.simonsz.2009.158">Simonsz et al 2009</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>In a large Mennonite cohort with incomplete X-linked CSNB, at least one of the following was <bold>not</bold> present in 72% of cases: myopia, nystagmus, or night blindness [<xref ref-type="bibr" rid="csnb.REF.boycott.2000.204">Boycott et al 2000</xref>].</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Normal color vision.</bold> However, individuals with a severe X-linked CSNB may show mild color vision deficits.</p>
              </list-item>
              <list-item>
                <p><bold>Normal fundus examination.</bold> However, persons with high myopia may show myopic degeneration.</p>
              </list-item>
              <list-item>
                <p>
                  <bold>Family history consistent with X-linked inheritance</bold>
                </p>
              </list-item>
              <list-item>
                <p>
                  <bold>Characteristic findings on ERG</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>ERG is used to assess the changes in electrical activity of the retina in response to light. The b-wave is caused by the depolarization of ON bipolar cells in response to light stimuli and is strictly dependent on synaptic transmission from photoreceptors to ON bipolar cells.</p>
                  </list-item>
                  <list-item>
                    <p>Individuals with X-linked CSNB have reduced scotopic b-wave amplitudes in response to bright flashes after dark adaptation (<xref ref-type="fig" rid="csnb.F1">Figure 1</xref>). The resulting ERG waveform is essentially a negative wave (amplitude of the a-wave is larger than that of the b-wave) [<xref ref-type="bibr" rid="csnb.REF.miyake.1986.1013">Miyake et al 1986</xref>], referred to as the Schubert-Bornschein form [<xref ref-type="bibr" rid="csnb.REF.schubert.1952.396">Schubert &#x00026; Bornschein 1952</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Based primarily on the results of the scotopic ERG, X-linked CSNB may be further differentiated as follows:</p>
                    <list list-type="bullet">
                      <list-item>
                        <p>Complete X-linked CSNB (CSNB1A): b-wave is severely reduced or not measurable (i.e., absent).</p>
                      </list-item>
                      <list-item>
                        <p>Incomplete X-linked CSNB (CSNB2A): b-wave is reduced but measurable.</p>
                      </list-item>
                    </list>
                  </list-item>
                  <list-item>
                    <p>The ERG can define specific retinal dysfunctions and, in general, differentiate the forms of X-linked CSNB (<xref ref-type="table" rid="csnb.T.erg_findings_in_complete_and_inco">Table 1</xref>) to identify the gene most likely to be involved (see <xref ref-type="sec" rid="csnb.Testing_Strategy">Testing Strategy</xref>).</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <table-wrap id="csnb.T.erg_findings_in_complete_and_inco" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>ERG Findings in Complete and Incomplete X-Linked CSNB</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">ERG Finding</th>
                    <th id="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Complete (CSNB1A)</th>
                    <th id="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Incomplete (CSNB2A)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Scotopic rod b-wave</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Severely reduced or absent</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Mixed scotopic a-wave</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Slightly reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Mixed scotopic b-wave</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Reduced</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Scotopic OP</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Slightly reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Photopic a-wave</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal, slightly reduced, saw-tooth (square) shaped</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Photopic b-wave</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Slightly reduced</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Photopic OP</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Lost, except for OP4</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All are lost</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">30-Hz flicker</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal/slightly reduced</td>
                    <td headers="hd_h_csnb.T.erg_findings_in_complete_and_inco_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Reduced with double peak</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>OP = oscillatory potential</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>Note: Pupillary responses have been described as "paradoxical" in the literature and textbooks (i.e., miosis of pupils when lights are turned off, as opposed to dilation). This description predates genotyping. In 17 individuals with incomplete X-linked CSNB ages five to 51 years examined by one of the authors, none clearly demonstrated a paradoxical papillary response. Further clarification of the presence or absence of this phenomenon in individuals with X-linked CSNB may require measurement with pupillometry.</p>
          </sec>
          <sec id="csnb.Carrier_Females">
            <title>Carrier Females</title>
            <p>In general, carrier females do not exhibit clinical signs of X-linked CSNB; however, on occasion there have been reports of females who are homozygous for pathogenic variants in <italic toggle="yes">CACNA1F</italic> with signs similar to those in males [<xref ref-type="bibr" rid="csnb.REF.bechhansen.1998.264">Bech-Hansen et al 1998</xref>].</p>
            <p>ERG changes that may be observed in obligate carriers of X-linked CSNB:</p>
            <list list-type="bullet">
              <list-item>
                <p>Reduced oscillatory potentials (OPs) associated with rod activity [<xref ref-type="bibr" rid="csnb.REF.rigaudi_re.2003.203">Rigaudi&#x000e8;re et al 2003</xref>]</p>
              </list-item>
              <list-item>
                <p>Reduced photopic b-wave and flicker amplitudes (with unaffected OPs) in one person [<xref ref-type="bibr" rid="csnb.REF.rigaudi_re.2003.203">Rigaudi&#x000e8;re et al 2003</xref>]</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="csnb.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Genes.</bold>
<italic toggle="yes">NYX</italic> and <italic toggle="yes">CACNA1F</italic> are the two genes in which pathogenic variants are known to cause X-linked CSNB. (See <related-object source-id="gene" document-id="csnb" object-id="csnb.molgen.TA">Table A</related-object> for chromosome locus and protein for these genes.)</p>
          <table-wrap id="csnb.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in X-Linked Congenital Stationary Night Blindness</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup> / CSNB Phenotype</th>
                  <th id="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of X-Linked CSNB Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">NYX</italic> / CSNB1A&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">45%</td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>6,&#x000a0;7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon and whole-gene deletions&#x000a0;<sup>7&#x000a0;9</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">CACNA1F</italic> / CSNB2A&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">55%</td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="table" rid="csnb.T.cacna1f_pathogenic_variants_discu">c.3167_3168dupC</xref>&#x000a0;<sup>11</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_csnb.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>6,&#x000a0;7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="csnb.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="csnb" object-id="csnb.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="csnb.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="csnb.REF.zeitz.2007.467">Zeitz [2007]</xref>
                </p>
              </fn>
              <fn id="csnb.TF.2.3">
                <label>3. </label>
                <p>See <xref ref-type="sec" rid="csnb.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="csnb.TF.2.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="csnb.REF.bechhansen.2000.319">Bech-Hansen et al [2000]</xref>, <xref ref-type="bibr" rid="csnb.REF.pusch.2000.324">Pusch et al [2000]</xref></p>
              </fn>
              <fn id="csnb.TF.2.5">
                <label>5. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="csnb.TF.2.6">
                <label>6. </label>
                <p>Lack of amplification by PCRs prior to sequence analysis can suggest a putative deletion of one or more exons or the entire X-linked gene in a male; confirmation may require additional testing by deletion/duplication analysis.</p>
              </fn>
              <fn id="csnb.TF.2.7">
                <label>7. </label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
              </fn>
              <fn id="csnb.TF.2.8">
                <label>8. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="csnb.TF.2.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="csnb.REF.pusch.2000.324">Pusch et al [2000]</xref>
                </p>
              </fn>
              <fn id="csnb.TF.2.10">
                <label>10. </label>
                <p><xref ref-type="bibr" rid="csnb.REF.bechhansen.1998.264">Bech-Hansen et al [1998]</xref>, <xref ref-type="bibr" rid="csnb.REF.strom.1998.260">Strom et al [1998]</xref></p>
              </fn>
              <fn id="csnb.TF.2.11">
                <label>11. </label>
                <p>Present in the Dutch-German Mennonite population [<xref ref-type="bibr" rid="csnb.REF.bechhansen.1998.264">Bech-Hansen et al 1998</xref>, <xref ref-type="bibr" rid="csnb.REF.boycott.2000.204">Boycott et al 2000</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="csnb.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To establish the diagnosis in a proband.</bold> A male with reduced visual acuity, myopia, nystagmus, strabismus, and normal color vision may be suspected of having X-linked CSNB. In general, the diagnosis of X-linked CSNB can be made by ophthalmologic examination (including electroretinography) and family history consistent with X-linked inheritance.</p>
          <p><bold>To confirm the diagnosis in a proband using molecular genetic testing</bold> (see <xref ref-type="table" rid="csnb.T.erg_findings_in_complete_and_inco">Table 1</xref>)</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Alternative 1.</bold> Sequential molecular genetic testing. For individuals with a clear family history consistent with X-linked inheritance, electroretinographic findings can be used to differentiate between CSNB1A and CSNB2A and can direct molecular genetic testing to the appropriate gene.</p>
              <p>Note: For individuals of Dutch-German Mennonite descent and features of CSNB2A, targeted analysis for the founder variant in <italic toggle="yes">CACNA1F</italic> can be performed.</p>
            </list-item>
            <list-item>
              <p><bold>Alternative 2.</bold> Multi-gene testing. For individuals without a clear family history consistent with X-linked inheritance, consider using a multi-gene congenital stationary night blindness panel that includes <italic toggle="yes">NYX</italic> and <italic toggle="yes">CACNA1F</italic> as well as additional genes associated with CSNB (see <xref ref-type="sec" rid="csnb.Differential_Diagnosis">Differential Diagnosis</xref>)<italic toggle="yes">.</italic> Note: Multi-gene panels vary by methods used and genes included; thus, the ability of a panel to detect a causative pathogenic variant(s) in any given individual with the CSNB phenotype also varies.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for this X-linked disorder and may develop some related findings.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="csnb.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="csnb.Clinical_Description">
          <title>Clinical Description</title>
          <p>X-linked congenital stationary night blindness (CSNB) is a congenital non-progressive retinal disorder characterized by defective night vision, reduced visual acuity, myopia, nystagmus, and strabismus (see <xref ref-type="sec" rid="csnb.Clinical_Diagnosis">Clinical Diagnosis</xref>).</p>
        </sec>
        <sec id="csnb.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>CSNB1A, the complete form of X-linked CSNB, is caused by mutation of <italic toggle="yes">NYX</italic> [<xref ref-type="bibr" rid="csnb.REF.bechhansen.2000.319">Bech-Hansen et al 2000</xref>, <xref ref-type="bibr" rid="csnb.REF.pusch.2000.324">Pusch et al 2000</xref>].</p>
          <p>CSNB2A, the incomplete form of X-linked CSNB, is caused by mutation of <italic toggle="yes">CACNA1F</italic> [<xref ref-type="bibr" rid="csnb.REF.bechhansen.1998.264">Bech-Hansen et al 1998</xref>, <xref ref-type="bibr" rid="csnb.REF.strom.1998.260">Strom et al 1998</xref>].</p>
        </sec>
        <sec id="csnb.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance of CSNB1A and CSNB2A is probably 100%, but expressivity is variable [<xref ref-type="bibr" rid="csnb.REF.boycott.2000.204">Boycott et al 2000</xref>]; clinically mild cases may be missed if electroretinography is not performed.</p>
        </sec>
        <sec id="csnb.Nomenclature">
          <title>Nomenclature</title>
          <p>X-linked CSNB has in the past been referred to as Schubert-Bornschein CSNB, which is a reference to the characteristic "negative" waveform (a-wave larger than the b-wave) of the ERG seen in both X-linked forms of CSNB [<xref ref-type="bibr" rid="csnb.REF.schubert.1952.396">Schubert &#x00026; Bornschein 1952</xref>].</p>
          <p>The terms CSNB1 and CSNB2 are sometimes used as abbreviations for complete and incomplete CSNB irrespective of the mode of inheritance; originally the terms referred to the two X-linked entities of CSNB.</p>
        </sec>
        <sec id="csnb.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of X-linked CSNB is not known.</p>
          <p>A founder effect has been reported in individuals with CSNB2A who are of Dutch-German Mennonite descent [<xref ref-type="bibr" rid="csnb.REF.bechhansen.1998.264">Bech-Hansen et al 1998</xref>, <xref ref-type="bibr" rid="csnb.REF.boycott.1998.865">Boycott et al 1998</xref>, <xref ref-type="bibr" rid="csnb.REF.boycott.2000.204">Boycott et al 2000</xref>]. A common pathogenic variant in <italic toggle="yes">NYX</italic> has been identified in Flemish individuals from Belgium with CSNB1A [<xref ref-type="bibr" rid="csnb.REF.leroy.2009.692">Leroy et al 2009</xref>].</p>
        </sec>
      </sec>
      <sec id="csnb.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">NYX</italic>.</bold> One other phenotype may be associated with mutation of <italic toggle="yes">NYX</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>High myopia</bold> in two unrelated males was associated with two novel pathogenic missense variants in <italic toggle="yes">NYX</italic>, suggesting that pathogenic variants in <italic toggle="yes">NYX</italic> may contribute to high myopia without additional features of X-linked CSNB [<xref ref-type="bibr" rid="csnb.REF.zhang.2007.330">Zhang et al 2007</xref>]. This observation needs to be substantiated by further studies.</p>
          </list-item>
        </list>
        <p><bold><italic toggle="yes">CACNA1F</italic>.</bold> Four other retinal phenotypes inherited in an X-linked manner are associated with mutation of <italic toggle="yes">CACNA1F</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>&#x000c5;land Island eye disease (AIED),</bold> also known as Forsius-Eriksson syndrome, is a retinal disorder characterized by fundus hypopigmentation, decreased visual acuity, nystagmus, astigmatism, protan color vision defect, progressive myopia, and defective dark adaptation. ERG reveals abnormalities in both photopic and scotopic functions. The phenotypic overlap between AIED and CSNB2A is significant. A novel pathogenic variant in <italic toggle="yes">CACNA1F</italic> has been identified in affected individuals from the original family with AIED [<xref ref-type="bibr" rid="csnb.REF.jalkanen.2007.2498">Jalkanen et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>X-linked cone-rod dystrophy (CORDX3)</bold> is characterized by modest progressive dysfunction of photoreceptors and several features of CSNB2A. A pathogenic variant in <italic toggle="yes">CACNA1F</italic> has been identified in one Finnish family [<xref ref-type="bibr" rid="csnb.REF.jalkanen.2006.699">Jalkanen et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>X-linked retinal disorder,</bold> described in a large Maori family [<xref ref-type="bibr" rid="csnb.REF.hope.2005.129">Hope et al 2005</xref>], shows clinical and ERG similarities to CSNB2A but, in addition, is associated with intellectual disability and manifestations in female carriers (attributed to a unique gain-of-function missense variant in <italic toggle="yes">CACNA1F</italic> [<xref ref-type="bibr" rid="csnb.REF.hemarawahanui.2005.7553">Hemara-Wahanui et al 2005</xref>]).</p>
          </list-item>
          <list-item>
            <p><bold>Retinal and optic atrophy,</bold> associated with progressive visual decline, has been described in two Japanese brothers [<xref ref-type="bibr" rid="csnb.REF.nakamura.2003.1028">Nakamura et al 2003</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="csnb.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS310500">Night blindness, congenital stationary: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        <sec id="csnb.Normal_Fundus">
          <title>Normal Fundus</title>
          <p>X-linked congenital stationary night blindness (X-linked CSNB) is characterized by a normal fundus. Only a few conditions may initially be confused with the X-linked form of CSNB:</p>
          <p><bold>CSNB (non X-linked).</bold> Family history consistent with X-linked inheritance may differentiate the X-linked forms of CSNB from the autosomal dominant and recessive forms (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS310500">OMIM Phenotypic Series</ext-link>).</p>
          <p><bold>Blue cone monochromacy</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/303700">303700</ext-link>), inherited in an X-linked manner, is characterized by poor vision and nystagmus. This condition differs clinically from X-linked CSNB in the following ways:</p>
          <list list-type="bullet">
            <list-item>
              <p>Color vision testing is abnormal.</p>
            </list-item>
            <list-item>
              <p>ERG reveals almost completely abolished photopic ERG contrasting with normal or minimally affected scotopic ERG.</p>
            </list-item>
            <list-item>
              <p>Whereas fundus examination in young males is normal, some males develop macular atrophy in late adulthood.</p>
            </list-item>
          </list>
          <p>Blue cone monochromacy results from alterations in the locus control region of the red and green pigment genes.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="xl-nystag" document-type="chapter"><bold>X-linked motor nystagmus</bold></related-object> can be distinguished from X-linked CSNB by the finding of normal ERG. Pathogenic variants in <italic toggle="yes">FRMD7</italic> are causative [<xref ref-type="bibr" rid="csnb.REF.tarpey.2006.1242">Tarpey et al 2006</xref>].</p>
        </sec>
        <sec id="csnb.Abnormal_Fundus">
          <title>Abnormal Fundus</title>
          <p>A few conditions with an abnormal fundus examination and an X-linked pattern of inheritance could be confused with X-linked CSNB.</p>
          <list list-type="bullet">
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="x-oa" document-type="chapter"><bold>X-linked ocular albinism</bold></related-object><bold>.</bold> Clinical features of iris transillumination and foveal hypoplasia are present in X-linked ocular albinism and not in CSNB. The ERG in X-linked ocular albinism does not show the selective reduction in the amplitude of the b-wave observed in X-linked CSNB. In X-linked ocular albinism the visual evoked potential (VEP) responses show a propensity for more crossing fibers than expected at the level of the chiasm. Pathogenic variants in <italic toggle="yes">OA1</italic> are causative.</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="retinoschisis" document-type="chapter"><bold>X-linked juvenile retinoschisis</bold></related-object><bold>.</bold> Visual acuity in X-linked juvenile retinoschisis is reduced to the same range seen in X-linked CSNB. Fundus examination shows foveal schisis or foveal findings in virtually all affected males and approximately 50% have areas of peripheral retinoschisis, neither of which finding is seen in X-linked CSNB. In X-linked juvenile retinoschisis the ERG shows a selective reduction in the amplitude of the b-wave. Pathogenic variants in <italic toggle="yes">RS1</italic> are causative.</p>
            </list-item>
          </list>
          <p>The following autosomal recessive conditions, also characterized by abnormal fundus, are included here as they are non-progressive and considered part of the spectrum of differential diagnoses of X-linked CSNB:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Oguchi disease</bold> is a form of CSNB reported in the Japanese that is caused by pathogenic variants in either <italic toggle="yes">SAG</italic>, the gene encoding arrestin, or <italic toggle="yes">GRK1</italic>, the gene encoding rhodopsin kinase. The fundus has an abnormal color, which becomes normal with prolonged dark adaptation (the Mizuo phenomenon) [<xref ref-type="bibr" rid="csnb.REF.dryja.2000.547">Dryja 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Fundus albipunctatus</bold> is a form of CSNB caused by pathogenic variants in <italic toggle="yes">RDH5</italic>, the gene encoding retinol dehydrogenase. The fundus shows discretely scattered white retinal dots. The ERG, when recorded under standard conditions, shows selective reduction in the b-wave, which normalizes with prolonged dark adaptation [<xref ref-type="bibr" rid="csnb.REF.dryja.2000.547">Dryja 2000</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="csnb.Management">
        <title>Management</title>
        <sec id="csnb.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with X-linked congenital stationary night blindness (CSNB), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Electroretinography</p>
            </list-item>
            <list-item>
              <p>Family history</p>
            </list-item>
            <list-item>
              <p>Dark adaptation (optional)</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="csnb.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Coincident high myopia or hyperopia can be managed with glasses or contact lenses.</p>
          <p>In some cases, conventional strabismus surgery may be required to improve binocularity or head posture.</p>
        </sec>
        <sec id="csnb.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Occasionally, a boy with X-linked CSNB may adopt a cosmetically unacceptable or functionally awkward head posture to dampen the degree of nystagmus in a particular position of gaze (the so-called "null point"). In some instances the position of gaze for the null point may be shifted to a better functional range by carefully planned strabismus surgery.</p>
        </sec>
        <sec id="csnb.Surveillance">
          <title>Surveillance</title>
          <p>Regular (yearly) eye examinations are recommended with refraction at a young age to monitor for the development of myopia.</p>
        </sec>
        <sec id="csnb.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Reduced visual acuity and difficulties seeing at night may preclude driving a car or restrict the class of driving license.</p>
        </sec>
        <sec id="csnb.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>For infants identified with high myopia, unusual head posture or nystagmus and a family history of CSNB, ophthalmic examination and molecular genetic testing may confirm the diagnosis of CSNB, obviating the need for neuroimaging or clinical electrophysiologic testing under sedation or general anesthesia.</p>
          <p>See <xref ref-type="sec" rid="csnb.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="csnb.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="csnb.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="csnb.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>X-linked congenital stationary night blindness (CSNB) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="csnb.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have X-linked CSNB nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected male, the mother of an affected male is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>Possible genetic explanations for a male proband with no family history of X-linked CSNB (i.e., a simplex case):</p>
              <list list-type="bullet">
                <list-item>
                  <p>He has a <italic toggle="yes">de novo</italic> pathogenic variant and his mother is not a carrier.</p>
                </list-item>
                <list-item>
                  <p>His mother has a <italic toggle="yes">de novo</italic> pathogenic variant either (a) as a "germline variant" (i.e., present at the time of her conception and therefore in every cell of her body); or (b) as "germline mosaicism" (i.e., present in some of her germ cells only). Germline mosaicism has not been reported in individuals with X-linked CSNB, but it has been observed in many X-linked disorders and should be considered in the genetic counseling of at-risk family members. In both instances (a) and (b), other offspring of the proband's mother are at risk of inheriting the pathogenic variant; however, the sibs of the proband's mother are not at risk of having inherited the altered gene.</p>
                </list-item>
                <list-item>
                  <p>His mother has a pathogenic variant that she inherited from a maternal female ancestor.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to sibs depends on the carrier status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has an altered allele, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the variant will be carriers and will usually not be affected. In rare cases a female is affected, having inherited two mutant alleles, one from a carrier mother and one from an affected father.</p>
            </list-item>
            <list-item>
              <p>If the altered allele cannot be detected in the DNA of the mother of the only affected male in the family, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Males with X-linked CSNB will pass the altered allele to all of their daughters and none of their sons.</p>
          <p><bold>Other family members of a proband.</bold> The proband's maternal aunts may be at risk of being carriers and the aunts' offspring, depending on their gender, may be at risk of being carriers or of having X-linked CSNB.</p>
        </sec>
        <sec id="csnb.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing of at-risk female relatives is possible if the pathogenic variant has been identified in the family.</p>
        </sec>
        <sec id="csnb.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="csnb.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and clarification of carrier status is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or are carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="csnb.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">NYX</italic> or <italic toggle="yes">CACNA1F</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for X-linked congenital stationary night blindness are possible.</p>
          <p>Requests for prenatal testing for conditions which (like X-linked CSNB) do not affect intellect or life span are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="csnb.Resources">
        <title>Resources</title>
      </sec>
      <sec id="csnb.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="csnb.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Genes associated with X-linked congenital stationary night blindness (X-linked CSNB) encode proteins that are specifically expressed in the retina: nyctalopin and voltage-dependent L-type calcium channel subunit alpha-1F (Ca<sub>v</sub>1.4/&#x003b1;<sub>1F</sub>) for complete and incomplete CSNB, respectively. Pathogenic variants identified in these genes impinge on synaptic transmission from photoreceptors (rods and cones) to inner retinal cells.</p>
          <sec id="csnb.NYX">
            <title>
              <italic toggle="yes">NYX</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">NYX</italic> spans approximately 28 kb of genomic DNA and comprises three exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="csnb" object-id="csnb.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> The spectrum of pathogenic variants is wide, including missense, nonsense, and splice site variants, deletions, and insertions. More than 50% of the pathogenic variants documented have been missense [<xref ref-type="bibr" rid="csnb.REF.zeitz.2005.179">Zeitz et al 2005</xref>, <xref ref-type="bibr" rid="csnb.REF.zeitz.2007.467">Zeitz 2007</xref>]. A common variant in a selected population has been reported (see <xref ref-type="sec" rid="csnb.Prevalence">Prevalence</xref>).</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">NYX</italic> encodes nyctalopin, a protein of 481 amino acids in the small leucine-rich proteoglycan family. Nyctalopin contains a signal peptide, a set of 12 leucine-rich repeats, and a glycosylphosphatidylinositol (GPI)-anchoring sequence [<xref ref-type="bibr" rid="csnb.REF.bechhansen.2000.319">Bech-Hansen et al 2000</xref>, <xref ref-type="bibr" rid="csnb.REF.pusch.2000.324">Pusch et al 2000</xref>, <xref ref-type="bibr" rid="csnb.REF.bechhansen.2005.815">Bech-Hansen et al 2005</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">NYX</italic> are predicted to cause a number of functional defects in nyctalopin, including alterations in its conformation, loss of the GPI anchor, and deletions of a portion or all of the protein [<xref ref-type="bibr" rid="csnb.REF.zeitz.2007.467">Zeitz 2007</xref>].</p>
          </sec>
          <sec id="csnb.CACNA1F">
            <title>
              <italic toggle="yes">CACNA1F</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CACNA1F</italic> spans approximately 28 kb of genomic DNA and comprises 48 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="csnb" object-id="csnb.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="csnb.T.cacna1f_pathogenic_variants_discu">Table 3</xref>. The spectrum of pathogenic variants is wide, including missense, nonsense, and splice site variants, deletions, and insertions. More than 50% of the pathogenic variants identified have been nonsense [<xref ref-type="bibr" rid="csnb.REF.zeitz.2005.179">Zeitz et al 2005</xref>, <xref ref-type="bibr" rid="csnb.REF.zeitz.2007.467">Zeitz 2007</xref>]. A founder variant in one population has been reported (see <xref ref-type="sec" rid="csnb.Prevalence">Prevalence</xref>).</p>
            <table-wrap id="csnb.T.cacna1f_pathogenic_variants_discu" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p><italic toggle="yes">CACNA1F</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_csnb.T.cacna1f_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_csnb.T.cacna1f_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_csnb.T.cacna1f_pathogenic_variants_discu_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_csnb.T.cacna1f_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3167_3168dupC<break/>(3166dupC)</td>
                    <td headers="hd_h_csnb.T.cacna1f_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu1056ProfsTer11<break/>(Leu991insC)</td>
                    <td headers="hd_h_csnb.T.cacna1f_pathogenic_variants_discu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=53832006">NM_005183.2</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="csnb.TF.3.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">CACNA1F</italic> encodes a protein in which one of the splice isoforms has 1966 amino acids (Ca<sub>v</sub>1.4/&#x003b1;<sub>1F</sub>) and is a voltage-gated L-type calcium channel [<xref ref-type="bibr" rid="csnb.REF.bechhansen.1998.264">Bech-Hansen et al 1998</xref>, <xref ref-type="bibr" rid="csnb.REF.strom.1998.260">Strom et al 1998</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Expression studies have shown that some (not all) <italic toggle="yes">CACNA1F</italic> pathogenic missense variants alter the channel activation properties of the Ca<sub>v</sub>1.4 calcium channel [<xref ref-type="bibr" rid="csnb.REF.mcrory.2004.1707">McRory et al 2004</xref>, <xref ref-type="bibr" rid="csnb.REF.hemarawahanui.2005.7553">Hemara-Wahanui et al 2005</xref>, <xref ref-type="bibr" rid="csnb.REF.hoda.2005.252">Hoda et al 2005</xref>]; other missense variants may affect the assembly or expression of the presynaptic ribbon complex [<xref ref-type="bibr" rid="csnb.REF.hoda.2006.1648">Hoda et al 2006</xref>]. Pathogenic nonsense and frameshift variants are predicted to cause loss of channel function or/and photoreceptor synapses.</p>
          </sec>
        </sec>
      </sec>
      <sec id="csnb.References">
        <title>References</title>
        <sec id="csnb.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="csnb.Literature_Cited.reflist0">
            <ref id="csnb.REF.allen.2003.1413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zito</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradshaw</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzke</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trump</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardcastle</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genotype-phenotype correlation in British families with X linked congenital stationary night blindness.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>87</volume>
                <fpage>1413</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">14609846</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.bechhansen.2005.815">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cockfield</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Logan</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Isolation and characterization of the leucine-rich proteoglycan nyctalopin gene (cNyx) from chick.</article-title>
                <source>Mamm Genome</source>
                <volume>16</volume>
                <fpage>815</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">16261423</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.bechhansen.1998.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maybaum</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koop</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mets</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musarella</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness.</article-title>
                <source>Nat Genet</source>
                <volume>19</volume>
                <fpage>264</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9662400</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.bechhansen.2000.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maybaum</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparkes</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koop</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergen</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prinsen</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polomeno</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drack</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musarella</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobson</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weleber</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>319</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11062471</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.boycott.2000.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F.</article-title>
                <source>Can J Ophthalmol</source>
                <volume>35</volume>
                <fpage>204</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">10900517</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.boycott.1998.865">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musarella</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weleber</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maybaum</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Evidence for genetic heterogeneity in X-linked congenital stationary night blindness.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>865</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">9529339</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.dryja.2000.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dryja</surname>
                    <given-names>TP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>130</volume>
                <fpage>547</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">11078833</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.hemarawahanui.2005.7553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hemara-Wahanui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berjukow</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hope</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dearden</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson-Wheeler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundon-Treweek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clover</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striessnig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marksteiner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hering</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maw</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>102</volume>
                <fpage>7553</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15897456</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.hoda.2005.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaghetto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koschak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striessnig</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels.</article-title>
                <source>J Neurosci</source>
                <volume>25</volume>
                <fpage>252</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15634789</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.hoda.2006.1648">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaghetto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koschak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striessnig</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression.</article-title>
                <source>J Neurochem</source>
                <volume>96</volume>
                <fpage>1648</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">16476079</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.hope.2005.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hope</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hemara-Wahanui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sissingh</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maw</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clover</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2.</article-title>
                <source>Clin Experiment Ophthalmol</source>
                <volume>33</volume>
                <fpage>129</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">15807819</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.jalkanen.2007.2498">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jalkanen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobias</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankila</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantyjarvi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsius</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alitalo</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel CACNA1F gene mutation causes Aland Island eye disease.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>48</volume>
                <fpage>2498</fpage>
                <lpage>502</lpage>
                <pub-id pub-id-type="pmid">17525176</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.jalkanen.2006.699">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jalkanen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantyjarvi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobias</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isosomppi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankila</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alitalo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bech-Hansen</surname>
                    <given-names>NT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>699</fpage>
                <lpage>704</lpage>
                <pub-id pub-id-type="pmid">16505158</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.leroy.2009.692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budde</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittmer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Baere</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeitz</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A common NYX mutation in Flemish patients with X linked CSNB.</article-title>
                <source>Br J Ophthalmol.</source>
                <volume>93</volume>
                <fpage>692</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18617546</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.mcrory.2004.1707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McRory</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamid</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doering</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamming</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beedle</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldcamp</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zamponi</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snutch</surname>
                    <given-names>TP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution.</article-title>
                <source>J Neurosci</source>
                <volume>24</volume>
                <fpage>1707</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">14973233</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.miyake.1986.1013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yagasaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horiguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawase</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Congenital stationary night blindness with negative electroretinogram. A new classification.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>104</volume>
                <fpage>1013</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">3488053</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.nakamura.2003.1028">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piao</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Retinal and optic disc atrophy associated with a CACNA1F mutation in a Japanese family.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>121</volume>
                <fpage>1028</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">12860808</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.pusch.2000.324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeitz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandau</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pesch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achatz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharfe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobi</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinckers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreasson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardcastle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissinger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>324</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11062472</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.rigaudi_re.2003.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rigaudi&#x000e8;re</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachapelle</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosolen</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gay-Duval</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Gargasson</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>ERGs in female carriers of incomplete congenital stationary night blindness (I-CSNB). A family report.</article-title>
                <source>Doc Ophthalmol</source>
                <volume>107</volume>
                <fpage>203</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">14661912</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.schubert.1952.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornschein</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1952</year>
                <article-title>Analysis of the human electroretinogram.</article-title>
                <source>Ophthalmologica</source>
                <volume>123</volume>
                <fpage>396</fpage>
                <lpage>413</lpage>
                <pub-id pub-id-type="pmid">14957416</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.simonsz.2009.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simonsz</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florijn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Minderhout</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergen</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamermans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Nightblindness-associated transient tonic downgaze (NATTD) in infant boys with chin-up head posture.</article-title>
                <source>Strabismus</source>
                <volume>17</volume>
                <fpage>158</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20001510</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.strom.1998.260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nyakatura</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apfelstedt-Sylla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellebrand</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wutz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutwillinger</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruther</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drescher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zrenner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenthal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness.</article-title>
                <source>Nat Genet</source>
                <volume>19</volume>
                <fpage>260</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9662399</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.tarpey.2006.1242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tarpey</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarvananthan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallya</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lisgo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surendran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinecke</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodruff</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Degg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Droutsas</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asproudis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zubcov</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veal</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Machado</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backhouse</surname>
                    <given-names>OC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumber</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Constantinescu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodsky</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertle</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edkins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Meara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teague</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wooster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futreal</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratton</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlob</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>1242</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17013395</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.zeitz.2007.467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeitz</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular genetics and protein function involved in nocturnal vision.</article-title>
                <source>Exp Rev Ophthalmol</source>
                <volume>2</volume>
                <fpage>467</fpage>
                <lpage>85</lpage>
              </element-citation>
            </ref>
            <ref id="csnb.REF.zeitz.2005.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeitz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minotti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyng</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness.</article-title>
                <source>Mol Vis</source>
                <volume>11</volume>
                <fpage>179</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15761389</pub-id>
              </element-citation>
            </ref>
            <ref id="csnb.REF.zhang.2007.330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jia</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sergeev</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejtmancik</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in NYX of individuals with high myopia, but without night blindness.</article-title>
                <source>Mol Vis</source>
                <volume>13</volume>
                <fpage>330</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17392683</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="csnb.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="csnb.Suggested_Reading.reflist0">
            <ref id="csnb.REF.dryja">
              <mixed-citation publication-type="web">Dryja TP. Retinitis pigmentosa and stationary night blindness. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 235. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/content.aspx?bookid=971&#x00026;Sectionid=62662092">online</ext-link>. Accessed 2-2-16.</mixed-citation>
            </ref>
            <ref id="csnb.REF.miyake.2006">
              <mixed-citation publication-type="book">Miyake Y. Congenital stationary blindness. In: Heckenlively JR, Arden GB, eds. <italic toggle="yes">Principles and Practice of Clinical Electrophysiology of Vision</italic>. 2 ed. Cambridge, MA: MIT Press; 2006:829-39.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="csnb.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="csnb.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors would like to thank Linda MacLaren and Karen McElligott for years of service to the Mennonite community affected with CSNB2A.</p>
        </sec>
        <sec id="csnb.Author_History">
          <title>Author History</title>
          <p>N Torben Bech-Hansen, PhD; University of Calgary, Canada (2007-2012)Kym M Boycott, PhD, MD (2007-present)Ian M MacDonald, MD, CM (2007-present)Yves Sauv&#x000e9;, PhD (2007-present)</p>
        </sec>
        <sec id="csnb.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>26 April 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 January 2008 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>9 August 2007 (im) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="csnb.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Representative full-field ERGs recorded from three males: A. Unaffected 35-year-old B. 66-year-old with CSNB1A (mutation in <italic toggle="yes">NYX</italic>) C. 35-year-old with CSNB2A (mutation in <italic toggle="yes">CACNA1F</italic>) Arrows indicate the b-wave, which has lower amplitude than the a-wave (so-called "negative ERG"). Traces in Panel C adapted with the author's permission from <xref ref-type="fig" rid="csnb.F1">Figure 1A</xref> of <xref ref-type="bibr" rid="csnb.REF.bechhansen.2000.319">Bech-Hansen et al [2000]</xref></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="csnb-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
